Sotera Health Co (NAS:SHC)

$ 12.02 0.43 (3.71%) Market Cap: 3.40 Bil Enterprise Value: 5.49 Bil PE Ratio: 63.26 PB Ratio: 7.92 GF Score: 75/100

Q1 2024 Sotera Health Co Earnings Call Transcript
May 02, 2024

$10.91 (-3.19%)

Earnings
Q4 2023 Sotera Health Co Earnings Call Transcript
Feb 27, 2024

$17.34 (+1.64%)

Earnings
Sotera Health Co at JPMorgan Healthcare Conference Transcript
Jan 09, 2024
Sotera Health Co at Wolfe Research Healthcare Conference Transcript
Nov 14, 2023
Q3 2023 Sotera Health Co Earnings Call Transcript
Nov 01, 2023

$12.87 (+1.66%)

Earnings
Q2 2023 Sotera Health Co Earnings Call Transcript
Aug 03, 2023

$17.58 (-4.87%)

Earnings
Sotera Health Co at RBC Capital Markets Global Healthcare Conference Transcript
May 16, 2023
Q1 2023 Sotera Health Co Earnings Call Transcript
May 03, 2023

$15.44 (-5.10%)

Earnings
Sotera Health Co at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum (Virtual) Transcript
Mar 21, 2023
Sotera Health Co at Barclays Global Healthcare Conference Transcript
Mar 16, 2023
Sotera Health Co at Citi Healthcare & Medtech Conference Transcript
Mar 02, 2023
Q4 2022 Sotera Health Co Earnings Call Transcript
Feb 28, 2023

$16.69 (-2.80%)

Earnings
Sotera Health Co at JPMorgan Healthcare Conference Transcript
Jan 10, 2023
Q3 2022 Sotera Health Co Earnings Call Transcript
Nov 02, 2022

$6.3 (-8.70%)

Earnings
Q2 2022 Sotera Health Co Earnings Call Transcript
Aug 04, 2022

$18.37 (+1.27%)

Earnings
Sotera Health Co at Goldman Sachs Global Healthcare Conference Transcript
Jun 14, 2022
Sotera Health Co at RBC Capital Markets Global Healthcare Conference Transcript
May 17, 2022
Q1 2022 Sotera Health Co Earnings Call Transcript
May 05, 2022

$20.8 (+0.29%)

Earnings
Q4 2021 Sotera Health Co Earnings Call Transcript
Mar 01, 2022

$21.37 (-2.29%)

Earnings
Sotera Health Co at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2022
Sotera Health Co at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 11, 2021
Q3 2021 Sotera Health Co Earnings Call Transcript
Nov 10, 2021

$24.12 (-10.80%)

Earnings
Sotera Health Co at Robert W Baird Global Healthcare Conference (Virtual) Transcript
Sep 14, 2021
Q2 2021 Sotera Health Co Earnings Call Transcript
Aug 12, 2021

$24.6 (+0.12%)

Earnings
Sotera Health Co Annual Shareholders Meeting Transcript
May 27, 2021
Sotera Health Co at RBC Capital Markets Global Healthcare Conference (Virtual) Transcript
May 18, 2021
Q1 2021 Sotera Health Co Earnings Call Transcript
May 13, 2021

$21.6 (-9.21%)

Earnings
Q4 2020 Sotera Health Co Earnings Call Transcript
Mar 09, 2021

$27.21 (+6.71%)

Earnings

Sotera Health Co at Barclays Global Healthcare Conference Transcript

Mar 16, 2023 / 01:00PM GMT

Release Date Price: $18.21 (+2.77%)

Transcript

Luke England Sergott

Barclays Bank PLC, Research Division - Research Analyst

Good morning, everybody. My name is Luke Sergott. I cover life sciences tools and diagnostics at Barclays. If you're not in Miami, you don't lose a voice, how are you going to prove you were there.

So with me, I have Michael Petras, CEO of Sotera Health. Thanks again, for making it down. Packed house on a Thursday, we're wrapping up the conference, and you guys are bringing it home for us. So, I guess we could start if you want to give a couple high-level thoughts or something prepared there, and then we could dig in some questions, if you like.

Michael B. Petras

Sotera Health Company - Chairman & CEO

Yes. Great. Thanks, Luke, for having us, and appreciate your support and Barclays Group overall. Happy to be here.

Before we begin, some of the statements I'm going to make are made considered forward-looking statements. Please refer to our SEC filings for a description of the risks and uncertainties that could cause our actual results to differ materially from

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.